Nordson Corporation · NASDAQ:NDSN

Nordson — Q1 2023 Earnings Presentation

16 slides from Nordson's earnings presentation, Feb 21, 2023

  1. Slide 1: 1Q Fiscal 2023 Webcast

    1Q Fiscal 2023 Webcast February 21, 2023 NBS NEXT OWNER MINDSET WINNING TEAMS

  2. Slide 2: Safe Harbor Statement

    Safe Harbor Statement Click to edit title Under the Private Securities Litigation Reform Act of 1995 Certain statements contained in this release are forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Forward-looking statements may be identified by

  3. Slide 3: Agenda

    Agenda 1Q Fiscal 2023 Webcast – February 21, 2023  First Quarter Highlights  Sales Performance and Earnings Review  Balance Sheet and Cash Flow  Enterprise Performance  FY 2023 and 2Q 2023 Guidance  Q&A Sundaram Nagarajan Joseph Kelley Lara Mahoney President and Executive Vice President, Vice

  4. Slide 4: Highlights

    Highlights  Solid first quarter revenue Diversity in product lines and  CyberOptics integration going geographies, NBS Next driving results well; strong contribution in quarter  Solid regional growth from the Americas and Europe, partially offset by currency headwinds and weakness in China  Gain

  5. Slide 5: Total Company – 1Q 2023

    Total Company – 1Q 2023 Sales 1Q 2023 Sales Bridge  Reported sales of $610M  Organic growth increased 1%; acquisitive growth of 3%; unfavorable currency impact of 4%  Strong combined 9% growth in Europe and Americas offset by weakness in Asia Pacific, primarily China Operating Profit* 1Q 2022 1Q

  6. Slide 6: Industrial Precision Solutions – 1Q 2023

    Industrial Precision Solutions – 1Q 2023 Sales $324  Sales of $312 million, decreased 4%  Organic growth of 1%, offset by unfavorable currency impact of 5%  Steady demand across most product lines and regions, offset by softness in Asia Pacific Operating Profit* Operating Profit and Margin $104 $

  7. Slide 7: Medical and Fluid Solutions – 1Q 2023

    Medical and Fluid Solutions – 1Q 2023 Sales  Sales of $154 million, decreased 3%  Organic sales decrease of 1%; unfavorable currency impact of 2%  Weakness was driven by medical fluid components and fluid solutions product lines in China, offset by strong demand for medical interventional solutio

  8. Slide 8: Advanced Technology Solutions – 1Q 2023

    Advanced Technology Solutions – 1Q 2023 Sales  14% sales increase, inclusive of 5% organic volume growth; 14% CyberOptics acquisition; 4% unfavorable currency impact  Organic growth driven by Americas region and test and inspection acoustic product lines, which benefits from new product innovation

  9. Slide 9: Balance Sheet and Cash Flow

    Balance Sheet and Cash Flow Strong Cash Flow with Sufficient Liquidity to Invest in Strategic Initiatives Net Debt Free Cash Flow  Cash totaled $122 million  $8 million increase, or 109% of adjusted net income  1.1 net debt leverage ratio based on trailing 12-month  Dividend payments of $37 mill

  10. Slide 10: Enterprise Highlights

    Enterprise Highlights  China operations returning to normal post-COVID spread; prioritizing health and safety  Continued site visits in the Americas and Europe, focused on accelerating NBS Next deployment  Dynamic 2023 includes changing demand trends 10

  11. Slide 11: End Market Visibility

    End Market Visibility Industrial Precision Solutions Advanced Technology Solutions Medical and Fluid Solutions • Increasing demand in automotive • Softening of semi-conductor orders • Strong growth in medical interventional • Steady demand in industrials and impacting electronics dispense systems, s

  12. Slide 12: Full-Year Fiscal 2023 Guidance

    Full-Year Fiscal 2023 Guidance Full-Year Sales Guidance Updating guidance, sustaining $2,590 $2,590 - $2,667 record 2022 performance $2,362  Fiscal 2023 sales growth of 0% - 3%  Adjusted earnings comparable to 2022  Remain invested in innovation and differentiated 2021 2022 2023 customer experien

  13. Slide 13: 2Q Fiscal 2023 Guidance

    2Q Fiscal 2023 Guidance 2Q 2023 Sales Guidance Managing dynamic market $635 $630 - $645 conditions $590  2Q 23 sales comparable to prior year, acquisition benefits are largely offset by currency headwinds  2Q 23 adjusted earnings per share in the range of $2.00 to $2.15 2Q 21 2Q 22 2Q 23  Order e

  14. Slide 14: Questions?

    Questions? Cordson

  15. Slide 15: Reconciliation of Non-GAAP Measures

    Reconciliation of Non-GAAP Measures Adjusted Operating Profit and EBITDA (Dollars in thousands) 15

  16. Slide 16: Reconciliation of Non-GAAP Measures

    Reconciliation of Non-GAAP Measures Profitability (Dollars in thousands) 16

Nordson — Q1 2023 Earnings Presentation on 6ix